Dr. Ons Bouchami is a distinguished microbiologist with over 20 years of research experience in molecular biology, microbiology, and antibiotic resistance. She holds a PhD in Biology from University de Tunis El Manar, Tunisia, with her doctoral research focusing on the genetic characterization of Staphylococcus species, which laid the foundation for her expertise in antimicrobial resistance mechanisms. Dr. Bouchami postdoctoral research at ITQB NOVA, Portugal, has been pivotal in advancing our understanding of bacterial evolution, particularly in nosocomial infections caused by methicillin resistant Staphylococcus species. Her work spans whole-genome sequencing, phylogenetic analysis, and the study of microbial resistance within hospital environments and the food production chain, highlighting the risk of zoonotic transmission of resistant bacteria. Currently, Dr. Bouchami is a key researcher at the Laboratory of Human Microbiota- Xenobiotics Interactions at ITQB NOVA. Her current projects include investigating the interaction between the gut microbiome and xenobiotics in the context of type 2 diabetes therapies, and the potential modulatory role of glycoprotein glycans on the gut microbiome. Her contributions to science include 34 peer-reviewed publications, one book, and numerous presentations at international conferences, reflecting her commitment to advancing global health through innovative research in microbiology and public health. Dr. Bouchami international collaborations and leadership in research projects make her a vital contributor to the scientific community, particularly in the fields of antimicrobial resistance and microbial genomics.

Dr. Hassan is a distinguished researcher renowned for his pioneering efforts in exploring novel antiviral drugs, with a specific focus on combating human herpesviruses. His commitment to advancing medical science extends beyond the laboratory, as evidenced by his editorial board membership in several prestigious international journals indexed in Web of Science (Clarivate Analytics) and Scopus. For detailed bibliographic insights into Dr. Hassan's scholarly contributions, his ORCID profile provides a comprehensive overview at https://orcid.org/0000-0003-3922-2738. Furthermore, Dr. Hassan's expertise and influence extend globally, as he has been invited as an organizing committee member and a keynote speaker to numerous national and international conferences and symposia. These engagements have taken him across diverse geographical landscapes, including the Czech Republic, Slovak Republic, Canada, Brazil, Italy, Belgium, England, Spain, and Malaysia, where he has shared his insights and discoveries with fellow researchers and scholars, fostering collaborative efforts to tackle pressing medical challenges.

M.Sc. Jorge Fragoso current role is Global Field Based Medical Excellence Lead in Sanofi Vaccines. In this function he oversees coordinating several initiatives related with Medical Science Liaison team around the globe. Jorge was born in Mexico City and is graduated from the National University of Mexico. He is a Biologist and holds a master's degree with honors in Neurosciences. Jorge joined Sanofi in 1991 and he drives his knowledge in Sales, Marketing, Business Support, e-business, training and Medical through more than 33 years of experience holding various roles in Pharma Mexico. Jorge joined the Latin America region team in 2010 and, since 2015, he has been coordinating several important initiatives at a Global level in Sanofi Vaccines. Those multidisciplinary functions provide to Jorge an interesting transversal view of the Pharma environment. As stretch activities, Jorge has been involved in many internal corporate initiatives. He currently is the President of AGE Connection.

Dr. Ivan Aloysius is the Principal GP and Joint Clinical Director at The Health Triangle PCN, part of the Ringmead Medical Group in Bracknell, UK. He is also the Immunisation Lead at Ringmead Medical Practice. Dr. Aloysius has a strong background in primary care research, with particular interests in influenza, vaccines, and overall health.